Fortrea's Alaric Jackson Talks AI in Clinical Trials

Fortrea’s Gani Chico Talks Oncology Innovation, AI and Clinical Trial Strategy

Optimize your product development journey and drive innovation with insightful guidance from our experienced global team

Flexible FSP resourcing meets evolving needs for an oncology biotech

Excellence in pharmacovigilance solutions: How Fortrea’s market-leading safety support enabled global operations for a leading pharmaceutical company

A framework for assessing the viability of an externally controlled arm for a single-arm trial

Jan Skoumal

• 26+ years of drug development experience specializing in immuno-oncology in Pharma/Biotech and CRO environments
• Provides operational executive leadership for Oncology study portfolio at Fortrea
• Chief Development Officer experi

Ken Morrison

Ken has over 30 years Clinical development experience across CROs, pharma & Biotech.

Obesity Highlights from the American Diabetes Association (ADA) 2025

Explore key obesity highlights from ADA 2025, including GLP-1, dual agonists, and insights shaping the future of obesity treatment.

Tanya Maltseva

Tanya Maltseva, Associate Medical Director is based in London, UK. She has over 25 years of experience in clinical research across academic, biopharma, and CRO settings.